Human Molecular Genetics, Vol 8, 2311-2316, Copyright © 1999 by Oxford University Press
G Zhou, Y Chen, L Zhou, K Thirunavukkarasu, J Hecht, D Chitayat, BD Gelb, S Pirinen, SA Berry, CR Greenberg, G Karsenty and B Lee
Cleidocranial dysplasia (CCD) is a dominantly inherited skeletal dysplasia
caused by mutations in the osteoblast-specific transcription factor CBFA1.
To correlate CBFA1 mutations in different functional domains with the CCD
clinical spectrum, we studied 26 independent cases of CCD and a total of 16
new mutations were identified in 17 families. The majority of mutations
were de novo missense mutations that affected conserved residues in the
runt domain and completely abolished both DNA binding and transactivation
of a reporter gene. These, and mutations which result in premature
termination in the runt domain, produced a classic CCD phenotype by
abolishing transactivation of the mutant protein with consequent
haploinsufficiency. We further identified three putative hypomorphic
mutations (R391X, T200A and 90insC) which result in a clinical spectrum
including classic and mild CCD, as well as an isolated dental phenotype
characterized by delayed eruption of permanent teeth. Functional studies
show that two of the three mutations were hypomorphic in nature and two
were associated with significant intrafamilial variable expressivity,
including isolated dental anomalies without the skeletal features of CCD.
Together these data show that variable loss of function due to alterations
in the runt and PST domains of CBFA1 may give rise to clinical variability,
including classic CCD, mild CCD and isolated primary dental anomalies.
ARTICLES
CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia
Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, BCM225, 630E, Houston, TX 77030, USA,
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.Y. Zhang, S.G. Zheng, Y.X. Wang, J.X. Zhu, X. Zhu, Y.M. Zhao, and L.H. Ge Novel RUNX2 Mutations in Chinese Individuals with Cleidocranial Dysplasia Journal of Dental Research, September 1, 2009; 88(9): 861 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, W. Pan, W. Xu, N. He, X. Chen, H. Liu, L. Darryl Quarles, H. Zhou, and Z. Xiao RUNX2 mutations in Chinese patients with cleidocranial dysplasia Mutagenesis, September 1, 2009; 24(5): 425 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.H. Jonason, G. Xiao, M. Zhang, L. Xing, and D. Chen Post-translational Regulation of Runx2 in Bone and Cartilage Journal of Dental Research, August 1, 2009; 88(8): 693 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
Zheng Shen, Chao Chun Zou, Rong Wang Yang, and Zheng Yan Zhao Cleidocranial Dysplasia: Report of 3 Cases and Literature Review Clinical Pediatrics, March 1, 2009; 48(2): 194 - 198. [Abstract] [PDF] |
||||
![]() |
Y. Lou, A. Javed, S. Hussain, J. Colby, D. Frederick, J. Pratap, R. Xie, T. Gaur, A. J. van Wijnen, S. N. Jones, et al. A Runx2 threshold for the cleidocranial dysplasia phenotype Hum. Mol. Genet., February 1, 2009; 18(3): 556 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Napierala, K. Sam, R. Morello, Q. Zheng, E. Munivez, R. A. Shivdasani, and B. Lee Uncoupling of chondrocyte differentiation and perichondrial mineralization underlies the skeletal dysplasia in tricho-rhino-phalangeal syndrome Hum. Mol. Genet., July 15, 2008; 17(14): 2244 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luan, X.-P. Yu, N. Yang, S. Frenkel, L. Chen, and C.-j. Liu p204 Protein Overcomes the Inhibition of Core Binding Factor {alpha}-1-mediated Osteogenic Differentiation by Id Helix-Loop-Helix Proteins Mol. Biol. Cell, May 1, 2008; 19(5): 2113 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xuan, S. Li, X. Zhang, F. Hu, L. Lin, C. Wang, and J. Zhang Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 15 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Gregory-Evans, M. Moosajee, M. D. Hodges, D. S. Mackay, L. Game, N. Vargesson, A. Bloch-Zupan, F. Ruschendorf, L. Santos-Pinto, G. Wackens, et al. SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma Hum. Mol. Genet., October 15, 2007; 16(20): 2482 - 2493. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Luan, X.-P. Yu, K. Xu, B. Ding, J. Yu, Y. Huang, N. Yang, P. Lengyel, P. E. Di Cesare, and C.-j. Liu The Retinoblastoma Protein Is an Essential Mediator of Osteogenesis That Links the p204 Protein to the Cbfa1 Transcription Factor Thereby Increasing Its Activity J. Biol. Chem., June 8, 2007; 282(23): 16860 - 16870. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Young, M. Q. Hassan, X.-Q. Yang, M. Galindo, A. Javed, S. K. Zaidi, P. Furcinitti, D. Lapointe, M. Montecino, J. B. Lian, et al. Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2 PNAS, February 27, 2007; 104(9): 3189 - 3194. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zhou, Q. Zheng, F. Engin, E. Munivez, Y. Chen, E. Sebald, D. Krakow, and B. Lee Dominance of SOX9 function over RUNX2 during skeletogenesis PNAS, December 12, 2006; 103(50): 19004 - 19009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ferrari Single Gene Mutations and Variations Affecting Bone Turnover and Strength: a Selective 2006 Update IBMS BoneKEy, December 1, 2006; 3(12): 11 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Wyckoff, C. El-Turk, A. Laptook, C. Timmons, F. H. Gannon, X. Zhang, S. Mumm, and M. P. Whyte Neonatal Lethal Osteochondrodysplasia with Low Serum Levels of Alkaline Phosphatase and Osteocalcin J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-j. Liu, E. Chang, J. Yu, C. S. Carlson, L. Prazak, X.-P. Yu, B. Ding, P. Lengyel, and P. E. D. Cesare The Interferon-inducible p204 Protein Acts as a Transcriptional Coactivator of Cbfa1 and Enhances Osteoblast Differentiation J. Biol. Chem., January 28, 2005; 280(4): 2788 - 2796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Amiel, D. Trochet, M. Clement-Ziza, A. Munnich, and S. Lyonnet Polyalanine expansions in human Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R235 - R243. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zheng, G. Zhou, R. Morello, Y. Chen, X. Garcia-Rojas, and B. Lee Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte-specific expression in vivo J. Cell Biol., September 1, 2003; 162(5): 833 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. Yan, C. J. Matheny, T. Corpora, J. Bravo, A. J. Warren, J. H. Bushweller, and N. A. Speck Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding J. Biol. Chem., August 29, 2003; 278(35): 33088 - 33096. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Michaud, F. Wu, M. Osato, G. M. Cottles, M. Yanagida, N. Asou, K. Shigesada, Y. Ito, K. F. Benson, W. H. Raskind, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis Blood, February 15, 2002; 99(4): 1364 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M Martin and J. L Gorski Ocular malformations, postaxial polydactyly, and delayed intramembranous ossification: a new autosomal dominant condition J. Med. Genet., August 1, 2001; 38(8): 547 - 551. [Full Text] [PDF] |
||||
![]() |
Y.-Y. Tang, J. Shi, L. Zhang, A. Davis, J. Bravo, A. J. Warren, N. A. Speck, and J. H. Bushweller Energetic and Functional Contribution of Residues in the Core Binding Factor beta (CBFbeta ) Subunit to Heterodimerization with CBFalpha J. Biol. Chem., December 8, 2000; 275(50): 39579 - 39588. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A. J. van Wijnen, J. B. Lian, G. S. Stein, and M. S. Nanes Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha J. Biol. Chem., January 18, 2002; 277(4): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||












